Turned on by danger: Activation of CD1d-restricted invariant natural killer T cells

Immunology

Volumn 137, Issue 1, 2012, Pages 20-27

  Lawson, Victoria ^a  

^a ProImmune Limited   (United Kingdom)

Author keywords

Immunity; Innate; Natural killer T cells; Non classical MHC; T cells; T cell receptor

Indexed keywords

ALPHA GALACTOSIDASE; ALPHA GALACTOSYLCERAMIDE; AUTOANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; CD1D ANTIGEN; GLYCEROPHOSPHATE; GLYCOSYLPHOSPHATIDYLINOSITOL; INTERLEUKIN 12; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ADVANCED CANCER; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN STRUCTURE; ASPERGILLUS; BACTERIAL INFECTION; BORRELIA; CANDIDA; CELL ACTIVATION; CELL ACTIVITY; CELL SURFACE; COMPLEMENTARITY DETERMINING REGION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DENDRITIC CELL; ESCHERICHIA COLI; HOST RESISTANCE; HOUSE DUST; HUMAN; IMMUNOLOGICAL MEMORY; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NATURAL KILLER T CELL; NONHUMAN; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION; SPHINGOMONAS; STREPTOCOCCUS PNEUMONIAE; TH1 CELL; TH2 CELL; UPREGULATION; VIRUS IMMUNITY; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1D; CYTOKINES; DENDRITIC CELLS; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, PATTERN RECOGNITION; TH1 CELLS; TH2 CELLS;

EID: 84864739900     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2012.03612.x     Document Type: Review

References (105)

1. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr Opin Immunol 2008; 20:358-68.
2. Zeng Z, Castaño AR, Segelke BW, Stura EA, Peterson PA, Wilson IA. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 1997; 277:339-45.
3. Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science 1997; 278:1626-9.
4. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, Kronenberg M. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 2000; 192:741-54.
5. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 2003; 4:1230-7.
6. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, Gapin L, Kronenberg M, Locksley RM. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 2003; 198:1069-76.
7. Matsuda JL, Gapin L, Baron JL, Sidobre S, Stetson DB, Mohrs M, Locksley RM, Kronenberg M. Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo. Proc Natl Acad Sci USA 2003; 100:8395-400.
8. Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001; 413:531-4.
9. Venkataswamy MM, Porcelli SA. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells. Semin Immunol 2010; 22:68-78.
10. Tupin E, Kinjo Y, Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 2007; 5:405-17.
11. Brennan PJ, Tatituri RV, Brigl M et al. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 2011; 12:1202-11.
12. Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol 2011; 11:131-42.
13. Novak J, Lehuen A. Mechanism of regulation of autoimmunity by iNKT cells. Cytokine 2011; 53:263-70.
14. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004; 114:1379-88.
15. Cui J, Shin T, Kawano T et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278:1623-6.
16. Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 2012; 12:239-52.
17. Song L, Asgharzadeh S, Salo J et al. Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J Clin Invest 2009; 119:1524-36.
18. Akbari O, Stock P, Meyer E et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003; 9:582-8.
19. Olszak T, An D, Zeissig S et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336:489-93.
20. Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat Immunol 2010; 11:197-206.
21. Godfrey DI, Pellicci DG, Patel O, Kjer-Nielsen L, McCluskey J, Rossjohn J. Antigen recognition by CD1d-restricted NKT T cell receptors. Semin Immunol 2010; 22:61-7.
22. Kinjo Y, Tupin E, Wu D et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006; 7:978-86.
23. Kinjo Y, Wu D, Kim G et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005; 434:520-5.
24. Mattner J, Debord KL, Ismail N et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005; 434:525-9.
25. Fischer K, Scotet E, Niemeyer M et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci USA 2004; 101:10685-90.
26. Chang YJ, Kim HY, Albacker LA et al. Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J Clin Invest 2011; 121:57-69.
27. Kinjo Y, Illarionov P, Vela JL et al. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 2011; 12:966-74.
28. Wingender G, Rogers P, Batzer G et al. Invariant NKT cells are required for airway inflammation induced by environmental antigens. J Exp Med 2011; 208:1151-62.
29. Paget C, Mallevaey T, Speak AO et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 2007; 27:597-609.
30. Salio M, Speak AO, Shepherd D et al. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc Natl Acad Sci USA 2007; 104:20490-5.
31. Wei DG, Lee H, Park SH, Beaudoin L, Teyton L, Lehuen A, Bendelac A. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J Exp Med 2005; 202:239-48.
32. Zhou D, Mattner J, Cantu C III et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004; 306:1786-9.
33. Porubsky S, Speak AO, Luckow B, Cerundolo V, Platt FM, Gröne HJ. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc Natl Acad Sci USA 2007; 104:5977-82.
34. Speak AO, Salio M, Neville DC et al. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc Natl Acad Sci USA 2007; 104:5971-6.
35. Christiansen D, Milland J, Mouhtouris E et al. Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation. PLoS Biol 2008; 6:e172.
36. Stanic AK, De Silva AD, Park JJ et al. Defective presentation of the CD1d1-restricted natural Vα14Jα18 NKT lymphocyte antigen caused by β-d-glucosylceramide synthase deficiency. Proc Natl Acad Sci USA 2003; 100:1849-54.
37. Muindi K, Cernadas M, Watts GF et al. Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d. Proc Natl Acad Sci USA 2010; 107:3052-7.
38. Joyce S, Woods AS, Yewdell JW et al.Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 1998; 279:1541-4.
39. Cox D, Fox L, Tian R, Bardet W, Skaley M, Mojsilovic D, Gumperz J, Hildebrand W. Determination of cellular lipids bound to human CD1d molecules. PLoS ONE 2009; 4:e5325.
40. Yuan W, Kang SJ, Evans JE, Cresswell P. Natural lipid ligands associated with human CD1d targeted to different subcellular compartments. J Immunol 2009; 182:4784-91.
41. Fox LM, Cox DG, Lockridge JL et al. Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol 2009; 7:e1000228.
42. Pei B, Speak AO, Shepherd D, Butters T, Cerundolo V, Platt FM, Kronenberg M. Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids. J Immunol 2011; 186:1348-60.
43. Facciotti F, Ramanjaneyulu GS, Lepore M et al. Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nat Immunol 2012; 13:474-80.
44. Castaño AR, Tangri S, Miller JE, Holcombe HR, Jackson MR, Huse WD, Kronenberg M, Peterson PA. Peptide binding and presentation by mouse CD1. Science 1995; 269:223-6.
45. Liu Y, Teige A, Mondoc E, Ibrahim S, Holmdahl R, Issazadeh-Navikas S. Endogenous collagen peptide activation of CD1d-restricted NKT cells ameliorates tissue-specific inflammation in mice. J Clin Invest 2011; 121:249-64.
46. Silk JD, Salio M, Reddy BG et al. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells. J Immunol 2008; 180:6452-6.
47. Kerzerho J, Yu ED, Barra CM et al. Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties. J Immunol 2012; 188:2254-65.
48. Borg NA, Wun KS, Kjer-Nielsen L et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 2007; 448:44-9.
49. Scott-Browne JP, White J, Kappler JW, Gapin L, Marrack P. Germline-encoded amino acids in the αβ T-cell receptor control thymic selection. Nature 2009; 458:1043-6.
50. Scott-Browne JP, Matsuda JL, Mallevaey T et al. Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat Immunol 2007; 8:1105-13.
51. Gadola SD, Koch M, Marles-Wright J et al. Structure and binding kinetics of three different human CD1d-α-galactosylceramide-specific T cell receptors. J Exp Med 2006; 203:699-710.
52. Zajonc DM, Savage PB, Bendelac A, Wilson IA, Teyton L. Crystal structures of mouse CD1d-iGb3 complex and its cognate Vα14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids. J Mol Biol 2008; 377:1104-16.
53. Wun KS, Borg NA, Kjer-Nielsen L et al. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J Exp Med 2008; 205:939-49.
54. Pellicci DG, Patel O, Kjer-Nielsen L et al. Differential recognition of CD1d-α-galactosyl ceramide by the Vβ8.2 and Vβ7 semi-invariant NKT T cell receptors. Immunity 2009; 31:47-59.
55. Pellicci DG, Clarke AJ, Patel O et al. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors. Nat Immunol 2011; 12:827-33.
56. Patel O, Pellicci DG, Uldrich AP et al. Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen. Proc Natl Acad Sci USA 2011; 108:19007-12.
57. Mallevaey T, Scott-Browne JP, Matsuda JL et al. T cell receptor CDR2 β and CDR3 β loops collaborate functionally to shape the iNKT cell repertoire. Immunity 2009; 31:60-71.
58. Sanderson JP, Waldburger-Hauri K, Garzón D et al. Natural variations at position 93 of the invariant Vα24-Jα18 α chain of human iNKT-cell TCRs strongly impact on CD1d binding. Eur J Immunol 2012; 42:248-55.
59. Florence WC, Xia C, Gordy LE et al. Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands. EMBO J 2009; 28:3579-90.
60. Matulis G, Sanderson JP, Lissin NM et al. Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3 β loop. PLoS Biol 2010; 8:e1000402.
61. Wu DY, Segal NH, Sidobre S, Kronenberg M, Chapman PB. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J Exp Med 2003; 198:173-81.
62. Mallevaey T, Clarke AJ, Scott-Browne JP et al. A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 2011; 34:315-26.
63. Wun KS, Cameron G, Patel O et al. A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells. Immunity 2011; 34:327-39.
64. Godfrey DI, Rossjohn J, McCluskey J. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity 2008; 28:304-14.
65. Li Y, Girardi E, Wang J, Yu ED, Painter GF, Kronenberg M, Zajonc DM. The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. J Exp Med 2010; 207:2383-93.
66. Patel O, Cameron G, Pellicci DG et al. NKT TCR recognition of CD1d-α-C-galactosylceramide. J Immunol 2011; 187:4705-13.
67. Wang J, Li Y, Kinjo Y, Mac TT, Gibson D, Painter GF, Kronenberg M, Zajonc DM. Lipid binding orientation within CD1d affects recognition of Borrelia burgdorferi antigens by NKT cells. Proc Natl Acad Sci USA 2010; 107:1535-40.
68. Girardi E, Yu ED, Li Y et al.Unique interplay between sugar and lipid in determining the antigenic potency of bacterial antigens for NKT cell. PLoS Biol 2011; 9:e1001189.
69. Yu ED, Girardi E, Wang J, Zajonc DM. Structural basis for the recognition of β-linked glycolipid antigens by invariant NKT cells. J Immunol 2011; 187:2079-83.
70. Goff RD, Gao Y, Mattner J et al. Effects of lipid chain lengths in α-galactosylceramides on cytokine release by natural killer T cells. J Am Chem Soc 2004; 126:13602-3.
71. McCarthy C, Shepherd D, Fleire S et al. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med 2007; 204:1131-44.
72. Bozna BL, Polzella P, Rankl C et al. Binding strength and dynamics of invariant natural killer cell T cell receptor/CD1d-glycosphingolipid interaction on living cells by single molecule force spectroscopy. J Biol Chem 2011; 286:15973-9.
73. Yu KO, Im JS, Molano A et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc Natl Acad Sci USA 2005; 102:3383-8.
74. Sullivan BA, Nagarajan NA, Wingender G et al. Mechanisms for glycolipid antigen-driven cytokine polarization by Vα14i NKT cells. J Immunol 2010; 184:141-53.
75. Chang YJ, Huang JR, Tsai YC, Hung JT, Wu D, Fujio M, Wong CH, Yu AL. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. Proc Natl Acad Sci USA 2007; 104:10299-304.
76. Wu TN, Lin KH, Chang YJ, Huang JR, Cheng JY, Yu AL, Wong CH. Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy. Proc Natl Acad Sci USA 2011; 108:17275-80.
77. Im JS, Arora P, Bricard G et al. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity 2009; 30:888-98.
78. Bai L, Sagiv Y, Liu Y et al. Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen αGalCer. Proc Natl Acad Sci USA 2009; 106:10254-9.
79. Bai L, Constantinides MG, Thomas SY et al.Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo. J Immunol 2012; 188:3053-61.
80. Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J Immunol 2001; 166:6012-8.
81. + invariant NKT cells. Blood 2007; 110:251-8.
82. Akbari O, Stock P, Singh AK et al. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunol 2010; 3:81-91.
83. Nowak M, Lynch L, Yue S, Ohta A, Sitkovsky M, Balk SP, Exley MA. The A2aR adenosine receptor controls cytokine production in iNKT cells. Eur J Immunol 2010; 40:682-7.
84. Parekh VV, Wilson MT, Olivares-Villagómez D, Singh AK, Wu L, Wang CR, Joyce S, Van Kaer L. Glycolipid antigen induces long-term natural killer T cell anergy in mice.
85. Kim S, Lalani S, Parekh VV, Vincent TL, Wu L, Van Kaer L. Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice. J Clin Invest 2008; 118:2301-15.
86. Wingender G, Hiss M, Engel I, Peukert K, Ley K, Haller H, Kronenberg M, von Vietinghoff S. Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans. J Immunol 2012; 188:3000-8.
87. Wang X, Chen X, Rodenkirch L et al. Natural killer T-cell autoreactivity leads to a specialized activation state. Blood 2008; 112:4128-38.
88. Raghuraman G, Geng Y, Wang CR. IFN-β-mediated up-regulation of CD1d in bacteria-infected APCs. J Immunol 2006; 177:7841-8.
89. Sköld M, Xiong X, Illarionov PA, Besra GS, Behar SM. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation. J Immunol 2005; 175:3584-93.
90. Berntman E, Rolf J, Johansson C, Anderson P, Cardell SL. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur J Immunol 2005; 35:2100-9.
91. Raftery MJ, Winau F, Giese T, Kaufmann SH, Schaible UE, Schönrich G. Viral danger signals control CD1d de novo synthesis and NKT cell activation. Eur J Immunol 2008; 38:668-79.
92. Lin Y, Roberts TJ, Spence PM, Brutkiewicz RR. Reduction in CD1d expression on dendritic cells and macrophages by an acute virus infection. J Leukoc Biol 2005; 77:151-8.
93. Renukaradhya GJ, Webb TJ, Khan MA, Lin YL, Du W, Gervay-Hague J, Brutkiewicz RR. Virus-induced inhibition of CD1d1-mediated antigen presentation: reciprocal regulation by p38 and ERK. J Immunol 2005; 175:4301-8.
94. Sanchez DJ, Gumperz JE, Ganem D. Regulation of CD1d expression and function by a herpesvirus infection. J Clin Invest 2005; 115:1369-78.
95. Rao P, Pham HT, Kulkarni A, Yang Y, Liu X, Knipe DM, Cresswell P, Yuan W. Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function. J Virol 2011; 85:8093-104.
96. Moll M, Andersson SK, Smed-Sörensen A, Sandberg JK. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 2010; 116:1876-84.
97. Darmoise A, Teneberg S, Bouzonville L, Brady RO, Beck M, Kaufmann SH, Winau F. Lysosomal α-galactosidase controls the generation of self lipid antigens for natural killer T cells. Immunity 2010; 33:216-28.
98. Chen X, Wang X, Keaton JM, Reddington F, Illarionov PA, Besra GS, Gumperz JE. Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules. J Immunol 2007; 178:6181-90.
99. Cohen NR, Tatituri RV, Rivera A et al. Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi. Cell Host Microbe 2011; 10:437-50.
100. Mallevaey T, Zanetta JP, Faveeuw C et al. Activation of invariant NKT cells by the helminth parasite Schistosoma mansoni. J Immunol 2006; 176:2476-85.
101. van Dommelen SL, Tabarias HA, Smyth MJ, Degli-Esposti MA. Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J Virol 2003; 77:1877-84.
102. Tyznik AJ, Tupin E, Nagarajan NA, Her MJ, Benedict CA, Kronenberg M. Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J Immunol 2008; 181:4452-6.
103. Wesley JD, Tessmer MS, Chaukos D, Brossay L. NK cell-like behavior of Vα14i NK T cells during MCMV infection. PLoS Pathog 2008; 4:e1000106.
104. Nagarajan NA, Kronenberg M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol 2007; 178:2706-13.
105. van der Vliet HJ, Wang R, Yue SC, Koon HB, Balk SP, Exley MA. Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cells. J Immunol 2008; 180:7287-93.